SOM BIOTECH LICENSES ITS FIRST DRUG

Posted on July 5, 2013 by admin

SOM has licensed to the biotech ARGON Pharma a new product with potential properties for the treatment of multiforme glioblastoma. The compound was discovered by SOM as SOM0777.

SOM Biotech

Baldiri Reixac, 4 (08028) Barcelona, Spain
Phone: +34 934 020 150
Email: info@sombiotech.com

Information

Subscribe to our newsletter

Leave this field empty if you're human:

About
Pipeline
Partnership
News & Events
- News
- Events calendar
Contact
Investors

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings ACCEPT

Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.